Guidance for establishing an integrative oncology service in the Australian healthcare setting : a discussion paper

Suzanne J. Grant, Jennifer Hunter, Alan Bensoussan, Geoff P. Delaney

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Abstract

There is an obvious mismatch between the high reported rates of use of traditional and complementary medicines (T&CM) by Australian cancer patients and cancer survivors and the low numbers of Australian cancer services integrating T&CM. An estimated 65% of Australian cancer patients use at least one form of T&CM. Over half use T&CM in conjunction with conventional cancer therapy. Yet, less than 20% of Australian hospital cancer care facilities provide access to T&CM. This compares to around 70% of UK cancer care facilities offering at least one T&CM therapy. Barriers to developing integrative oncology services include determining an appropriate service model and revenue structure; concerns with ethical and legal issues such as regulations and credentialing; and inadequate high-quality scientific evidence demonstrating safety and effectiveness, including concerns about the possibility of adversely affecting chemotherapy or radiotherapy treatment. This paper aims to provide general guidance and practical strategies for those seeking to develop integrative oncology services in Australian cancer care facilities.
Original languageEnglish
Pages (from-to)471-481
Number of pages11
JournalSupportive Care in Cancer
Volume26
Issue number2
DOIs
Publication statusPublished - 2018

Keywords

  • alternative medicine
  • cancer
  • integrative medicine
  • medical care

Fingerprint

Dive into the research topics of 'Guidance for establishing an integrative oncology service in the Australian healthcare setting : a discussion paper'. Together they form a unique fingerprint.

Cite this